Incorporated in 2006 and headquartered in Connecticut, SurgiQuest set it sights on developing a radically different laparoscopic trocar design that eliminated the circular seals and duckbill valves that had plagued conventional trocars since the early 1990's.Company executives, many of whom came from stapling and laparoscopy pioneer United States Surgical Corporation, immediately recognized that SurgiQuest's technology had the capability to transform laparoscopic surgery not only by eliminating the hassles of conventional trocars which included scope smudging, fragmented specimen removal, and seal disintegration but by enabling the use of multiple instruments and tools that were no longer limited to cylindrical design.